mutLBSgeneDB |
Gene summary for DIRAS2 |
![]() |
Basic gene Info. | Gene symbol | DIRAS2 |
Gene name | DIRAS family, GTP-binding RAS-like 2 | |
Synonyms | Di-Ras2 | |
Cytomap | UCSC genome browser: 9q22.2 | |
Type of gene | protein-coding | |
RefGenes | NM_017594.3, | |
Description | GTP-binding protein Di-Ras2distinct subgroup of the Ras family member 2 | |
Modification date | 20141207 | |
dbXrefs | MIM : 607863 | |
HGNC : HGNC | ||
Ensembl : ENSG00000165023 | ||
HPRD : 09711 | ||
Vega : OTTHUMG00000020196 | ||
Protein | UniProt: Q96HU8 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DIRAS2 | |
BioGPS: 54769 | ||
Pathway | NCI Pathway Interaction Database: DIRAS2 | |
KEGG: DIRAS2 | ||
REACTOME: DIRAS2 | ||
Pathway Commons: DIRAS2 | ||
Context | iHOP: DIRAS2 | |
ligand binding site mutation search in PubMed: DIRAS2 | ||
UCL Cancer Institute: DIRAS2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0043406 | positive regulation of MAP kinase activity | 12194967 |
Top |
Ligand binding site mutations for DIRAS2 |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | T39 | T39M | BRCA | 1 | R33 | R33W | COAD | 1 | A152 | A152T | COAD | 1 | T39 | T39M | COAD | 1 | T39 | P38Q | LUAD | 1 | R33 | R33L | LUAD | 1 | T39 | P38L | SKCM | 1 | R33 | R33W | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for DIRAS2 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | T39 | P38Q | -1.0034887 | T39 | T39M | -0.76613844 | A152 | A152T | -0.69944977 | R33 | R33W | -0.4717569 | T39 | P38L | -0.46381808 | R33 | R33L | -0.20018816 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for DIRAS2 |
![]() |
![]() |
Top |
Top |
Phenotype information for DIRAS2 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for DIRAS2 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | GDP | GUANOSINE-5'-DIPHOSPHATE | 2erx | A | R33 A152 | GDP | GUANOSINE-5'-DIPHOSPHATE | 2erx | B | R33 A152 | PO4 | PHOSPHATE ION | 2erx | A | T39 | MG | MAGNESIUM(2+) | 2erx | A | T39 | PO4 | PHOSPHATE ION | 2erx | B | T39 | MG | MAGNESIUM(2+) | 2erx | B | T39 |
Top |
Conservation information for LBS of DIRAS2 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |